Stay updated on Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Sign up to get notified when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page footer's revision tag was updated from v3.6.0 to v3.6.2, indicating a backend or template update; the visible study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-06-26T23:56:12.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    New metadata and navigation elements were added: Weijia Fang, MD appears as the contact line, verification-related labels were introduced, and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. Formatting was standardized from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag was updated to v3.6.0.
    Difference
    2%
    Check dated 2026-06-12T16:31:41.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.4 to v3.5.5, indicating a new version of the page has been published. This revision update is a backend/version control detail rather than a substantive content change.
    Difference
    0.1%
    Check dated 2026-06-05T13:23:38.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now shows a new revision label Revision: v3.5.4, replacing the prior Revision: v3.5.3. This indicates a minor update to the page's metadata or presentation.
    Difference
    0.1%
    Check dated 2026-05-15T05:50:14.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page’s revision/version footer was updated from **v3.5.2** to **v3.5.3**, reflecting a site build or documentation update rather than a change to the clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:56.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:44:08.000Z thumbnail image

Stay in the know with updates to Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib, Toripalimab & Chemo in 2nd-line CRC Clinical Trial page.